Pharmaids Pharmaceuticals Share Price
31.50-0.48 (-1.50%)
-48.34% past 1 Year
Pharmaids Pharmaceuticals Ltd manufacture herbal cough syrups cold tablets pain reliever tablets active charcoal tablets joint pain ointments and much more. They are established in the year 1991 and are
Corporate filings & documents
Announcements
Enclosed copies of Newspaper Advertisement published on August 19 2026 intimating the Notice of 37th Annual General Meeting of the Company
2 weeks agoEnclosed copies of Newspaper Advertisement published on August 19 2026 intimating the Notice of 37th Annual General Meeting of the Company
2 weeks agoAnnual Report
2 weeks agoAnnual Report
2 weeks agoNotice of 37th AGM and Annual Report
2 weeks agoNotice of 37th AGM and Annual Report
2 weeks agoNewspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30 2026
3 weeks agoNewspaper publication of unaudited financial results (standalone & consolidated) for the quarter ended June 30 2026
3 weeks agoSubmission of unaudited financial results
3 weeks agoSubmission of unaudited financial results
3 weeks agoOutcome of the Board meeting held today i.e. August 12 2026
3 weeks agoOutcome of the Board meeting held today i.e. August 12 2026
3 weeks agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026.
4 weeks agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter ended 30th June 2026.
4 weeks agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.
1 month agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended June 30 2026.
1 month agoAppointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
2 months agoAppointment of M/s. V Mahendra & Associates as the Internal Auditors of the Company for carrying out the Internal Audit for the financial year 2026-27.
2 months agoIntimation w.r.t Closure of Trading Window
2 months agoIntimation w.r.t Closure of Trading Window
2 months agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you of the change in Senior Management Personnel of the Company.
2 months agoPursuant to the provisions of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we wish to inform you of the change in Senior Management Personnel of the Company.
2 months agoAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015 - Providing corporate guarantee to subsidiary Adita Bio Sys Private Limited
2 months agoAnnouncement under Regulation 30 of SEBI (LODR) Regulations 2015 - Providing corporate guarantee to subsidiary Adita Bio Sys Private Limited
2 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026
3 months agoNewspaper publication of Audited Financial Results (Standalone and Consolidated) for the quarter and year ended March 31 2026
3 months agoSubmission of Audited Financial Results along with Auditors Report.
3 months agoThe Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31 2026 at their meeting held on May 29 2026.
3 months agoThe Board of Directors of the Company have approved the Audited Financial Results for the quarter and year ended March 31 2026 at their meeting held on May 29 2026.
3 months agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2026.
3 months agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 inter alia to consider and approve the Audited Financial Results (Standalone and Consolidated) for the quarter and year ended 31st March 2026.
3 months agoPursuant to the Regulation 24A of SEBI (LODR) Regulations 2015 enclosed is the Annual Secretarial Compliance Report for the year ended March 31 2026.
3 months agoNewspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
4 months agoNewspaper publication regarding the Special Window open for Re-Lodgement of transfer deeds.
4 months agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.
5 months agoCertificate under Regulation 74(5) of the SEBI (Depositaries and Participants) Regulations 2018 for the quarter ended March 31 2026.
5 months agoSale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited a step-down subsidiary resulting in cessation of its subsidiary status w.e.f March 27 2026.
5 months agoSale of entire shareholding held by Adita Bio Sys Private Limited (material subsidiary of the Company) in Siri Labvivo Diet Private Limited a step-down subsidiary resulting in cessation of its subsidiary status w.e.f March 27 2026.
5 months agoIntimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.
5 months agoIntimation of Trading Window Closure pursuant to declaration of Audited Financial Results for the quarter and Year ended March 31 2026.
5 months agoIntimation under Regulation 30 of LODR.
6 months agoCorrigendum to the newspaper publication dated February 14 2026 regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
6 months agoCorrigendum to the newspaper publication dated February 14 2026 regarding unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
6 months agoNewspaper Publication of unaudited financial results (Consolidated and Standalone) for the quarter and nine months ended December 31 2025.
6 months agoReport of Auditors on Financial Results for the quarter and nine months ended December 31 2025 with UDIN
6 months agoUnaudited financial results for the quarter and nine months ended December 31 2025
6 months agoOutcome of the Board Meeting held on Thursday February 12 2026 i.e today to consider and approve the un-audited financial results for the quarter and nine months ended December 31 2025.
6 months agoPharmaids Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Financial Results (Standalone and Consolidated) for the quarter and nine months ended December 31 2025.
6 months agoReport on shares re-lodged for transfer cum Demat of Physical shares.
7 months agoCertificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2025.
7 months agoAnnual reports
Concalls & investor presentations
No presentations found
Corporate Actions
Date
Type
Details
No data available.
Company details
Registered office
Unit 201, 2nd Floor, Brigade Rubix 20/14, H M T Factory Main Road Peenya Plantation Bengaluru Karnataka PIN: 560013 Tel No: 080- 49784319 Fax No: NULL Email: [email protected] Internet: www.pharmaids.com
Registrars
Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57, 4th & 5th Floors, Jayabheri Enclave Phase - II, Gachibowli(Old Address:12-10-167, MIG- 167,Bharat Nagar Colony, Hyderabad – 500018.)Phone: +91-40-23818475/6Fax : +91-40-23868024Email: info@vccili Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57 4th & 5th Floors Jayabheri Enclave Phase - II, Gachibowli PIN: Tel No: 23818475,23868257,35164910 Fax No: NULL Email: [email protected] Internet: www.vccipl.com
Management
Prasanna Subramanya Bhat, Company Secretary & Compliance Officer
Pattamadai Natarajasarma Vijay, Chairman
Shankarappa Nagaraja Vinaya Babu, Vice Chairman
Shreedhara Shetty, Non Independent & Non Executive Director
Yogananda Moolemath, Non Executive Independent Director
Methuku Nagesh, Non Executive Independent Director
Venu Madhava Kaparthy, Whole Time Director
Mini Manikantan, Whole Time Director
Details
BSE 524572
NSE NULL
ISIN INE117D01018